The groundbreaking therapy of the medication represents a major development in the care of the condition. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – providing greater sugar https://tirzepatide-peptide203906.blogscribble.com/42319863/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment